XML 42 R29.htm IDEA: XBRL DOCUMENT v3.24.4
Income Taxes (Tables)
 12 Months Ended
Sep. 30, 2024
Income Taxes [Abstract]  
Schedule of U.S. Federal Income Tax Rate to Pretax Income The income tax expense (benefit) differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income for the years ended September 30, 2024 and 2023 due to the following:
    2024     2023  
Computed “expected” tax benefit     (21.0 )%     (21.0 )%
Increase (decrease) in income taxes resulting from:                
State taxes, net of federal benefit     (6.3 )     (6.3 )
Permanent differences     5.5       3.7  
Increase in the valuation reserve     23.3       25.4  
      1.5 %     1.78 %
Schedule of Company’s Deferred Tax Assets and Liabilities Significant components of the Company’s deferred tax assets and liabilities are as follows:
   September 30,
2024		   September 30,
2023		 
Deferred tax assets:        
Net operating loss carryforward  $39,888,000   $34,980,000 
Stock-based compensation   3,310,000    2,191,000 
Capitalized research and development   5,762,000    3,644,000 
Other   4,861,000    4,100,000 
Valuation allowance on deferred tax assets   (53,821,000)   (44,915,000)
Total deferred tax assets   
—
    
—
 
Deferred tax liabilities:          
In-process research and development   (6,713,800)   (6,137,800)
Total deferred tax liability   (6,713,800)   (6,137,800)
Net deferred tax liability  $(6,713,800)  $(6,137,800)